The rebrand comes on the heels of the company acquiring Cook Biotech and Collagen Solutions. Evergen is the industry’s only CDMO to offer a comprehensive portfolio of allograft and xenograft biologics, according to a Dec. 17 news release.
Evergen’s regenerative medicine portfolio includes products for orthopedics, neurosurgery and sports medicine.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
